Trial Profile
A randomized, double blind, two-period cross-over trial investigating the effect of liraglutide as add on to intensive insulin treatment on the endogenous glucose production in subjects with C-peptide positive type 1 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 08 Sep 2017 Status changed from recruiting to completed.
- 29 Jul 2014 New trial record